Cardiovascular Drugs Global Market Report 2018

Starting Price : $ 4000.00 | Pages : 125 | Published : February 2018 | SKU CODE : 3250 | Format :

Cardiovascular drugs market covers the drugs used to treat conditions that affect the heart or blood vessels. These conditions include heart stroke, coronary artery diseases, valvular diseases, peripheral venous diseases, pericarditis, endocarditis, cardiac tumors, arteriosclerosis, and lymphatic diseases. Some of the major cardiovascular drugs include anti-hypertensive drugs such as calcium channel blockers and Angiotensin II receptor antagonists, and hypolipidemic drugs such as fibric acid derivatives and bile acid binding resins.

The global cardiovascular drugs market was valued at around $129 billion in 2017. North America was the largest region in the cardiovascular drugs market in 2017, accounting for nearly 40% market share. The USA was the largest country in the market in 2017, accounting for nearly 25% market share.
The innovation of gene testing technologies for the development of personalized medicine for cardiovascular diseases is one of the major trends in the market. Due to the reduction in the cost of gene testing, patients can screen for their predisposition for specific cardiovascular diseases. Gene testing helps in the development of personalized pharmacogenomic agents and improved patient monitoring efforts for cardiovascular disorders and detect them before an onset of acute care episodes.

The top five companies covered are Merck & Co., Sanofi S.A., Pfizer Inc., Bristol-Myers Squibb Company and Novartis AG. Merck & Co. was the largest company in the cardiovascular drugs market in 2017.

The countries covered are USA, China, Germany, Brazil, Japan, UK, Spain, Russia, France, Australia, Italy, India and rest of the world.

The cardiovascular drugs market is segmented into Anti-Hypertensive Drugs, Hypolipidemic Drugs, Antithrombotics Drugs and Other (Congestive Heart Failure, Antiarrhythmic and Antianginal) Drugs.
Anti-Hypertensive Drugs are used to prevent heart failure, kidney failure and acute stroke induced by hypertension. These companies also offer drugs to control blood pressure and delay the development of atherosclerosis.
Hypolipidemic Drugs are those drugs that lower lipid and lipoproteins levels in the blood.
Antithrombotics Drugs are used to prevent and treat arterial and venous thrombosis.
Other (Congestive Heart Failure, Antiarrhythmic and Antianginal) Drugs are the drugs that prevent congestive heart failure, drugs used for the treatment of cardiovascular diseases, antiarrhythmic drugs used for the treatment of abnormal heart rhythms, and antianginal drugs used for angina management.

Over 1000 Biologics Under Development Will Drive The Biologics Market To 10% Yearly Growth

Public Policy Restrains Blood Glucose Test Strips Market Growth

The Leading Players In The Cardiovascular Devices Market Are Innovating To Stay Ahead

India Is The World’s Fastest-Growing Market For In-Vitro Diagnostics

Lower Average Prices Will Affect Global Market For Blood Glucose Test Strips

Neurology Devices Are Replacing Drugs As First Treatment Preference

Eastern Europe Is The Fastest-Growing Region For The Cancer Drugs Market

Increased Pet Ownership Drives Veterinary Services Market Growth

Veterinary Services Global Market Report 2018

View Report

Blood Glucose Test Strips Global Market Report 2018

View Report

Nephrology And Urology Devices Market Global Briefing 2018

View Report

Neurology Devices Market Global Briefing 2018

View Report

ENT Devices Market Global Briefing 2018

View Report

Orthopedic Devices Market Global Briefing 2018

View Report

Wound Care Devices Market Global Briefing 2018

View Report

Diabetes Care Devices Market Global Briefing 2018

View Report

Call Us

+1 3156230293

(Americas)

+44 2071930708

(Europe)

+91 8897263534

(Asia & Others)